To the Editor: Intravenous multivitamin solution has not beenmanufactured in the United States for some time, and suppliesare nearly depleted. Thus, since the end of 1996 this preparationhas not been available for many patients requiring parenteralnutrition.
A 41-year-old woman with spindle-cell cancer underwent a massivesmall-bowel resection in February 1996 that resulted in short-bowelsyndrome. She was receiving total parenteral nutrition whilebeing cared for at home. She received her last dose of intravenousmultivitamin solution in the total parenteral nutrition in November1996. In January 1997 she was hospitalized with nausea, vomiting,vertigo, and diplopia. . . . [Full Text of this Article]
This article has been cited by other articles:
Robien, K., Ulrich, C. M., Bigler, J., Yasui, Y., Gooley, T., Bruemmer, B., Potter, J. D., Radich, J. P.
(2004). Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia. Clin. Cancer Res.
10: 7592-7598
[Abstract][Full Text]
A.S.P E.N.,
(1998). Safe Practices for Parenteral Nutrition Formulations: National Advisory Group On Standards and Practice Guidelines for Parenteral Nutrition Approved By a.S.P.E.N. Board of Directors January 17, 1997. JPEN J Parenter Enteral Nutr
22: 49-66
Hahn, J. S., Berquist, W., Alcorn, D. M., Chamberlain, L., Bass, D.
(1998). Wernicke Encephalopathy and Beriberi During Total Parenteral Nutrition Attributable to Multivitamin Infusion Shortage. Pediatrics
101
: e10-e10
[Abstract][Full Text]